Key result
PFA-200 detects clopidogrel resistance in ~23% of hypercoagulable dogs, reversible with dose escalation.
Why the study?
The study aimed to evaluate the prevalence of clopidogrel resistance in hypercoagulable dogs using the PFA-200 P2Y cartridge and assess routine coagulation and TEG parameters as indicators of clopidogrel efficacy.
Does the PFA-200 P2Y cartridge effectively detect clopidogrel resistance in hypercoagulable dogs, and can dose escalation overcome this resistance?
Observational (n=70)
No
Does the PFA-200 P2Y cartridge effectively detect clopidogrel resistance in hypercoagulable dogs, and can dose escalation overcome this resistance?
The PFA-200 P2Y cartridge effectively detects clopidogrel resistance in dogs, which occurs in approximately 23% of hypercoagulable cases and can be successfully managed with dose escalation.
May inform clopidogrel dosing in resistant dogs; leaves open clinical translation pending prospective validation.
We aimed to evaluate the prevalence of clopidogrel resistance in hypercoagulable dogs using the Platelet Function Analyzer-200 (PFA-200) P2Y cartridge; further, we aimed to assess the utility of hematocrit (HCT), platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (aPTT), thromboelastography (TEG) parameters, and D-dimer level as indicators of clopidogrel efficacy. Forty healthy dogs underwent single measurements of P2Y closure time (CT), HCT, PLT, PT, aPTT, TEG parameters, and D-dimer levels, while thirty hypercoagulable dogs underwent two measurements of these parameters before and after clopidogrel treatment. The reference interval for P2Y CT in healthy dogs was 40.0–141.5 s, with a mean of 63.9 ± 26.82 s. Hypercoagulable dogs showed a mean baseline P2Y CT of 77.4 ± 37.6 s. Moreover, 23 (76.67%) and 7 (23.33%) showed responsiveness and resistance to the initial clopidogrel dose, respectively. The mean P2Y CT of the clopidogrel-resistant group after clopidogrel administration was 182.71 ± 78.43 s. Increasing the maintenance dose successfully overcame clopidogrel resistance in these seven dogs. Among the assessed parameters, only D-dimer levels showed a significant decrease in the clopidogrel-responder group ( p < 0.05), suggesting its potential utility in evaluating responsiveness. In conclusion, the PFA-200 P2Y cartridge effectively detects clopidogrel resistance in dogs and can guide therapeutic adjustments such as dose escalation.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2025) conducted an observational in Hypercoagulability (n=70). Clopidogrel vs. Baseline (pre-treatment) was evaluated on Clopidogrel responsiveness (P2Y CT > 300 s). The PFA-200 P2Y cartridge effectively detected clopidogrel resistance in 23.33% of hypercoagulable dogs, which was successfully overcome by increasing the maintenance dose.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: